Global Marine Biotechnology Market Growth (Status and Outlook) 2023-2029

Global Marine Biotechnology Market Growth (Status and Outlook) 2023-2029

Marine biotechnology is an innovative field of research in science and engineering that encompasses the use of marine bioresources for a multitude of applications, including the production of food, fuel, materials or specific, often bioactive, compounds and may contribute to green growth and sustainable industries and prosperous communities.Marine biotechnological advancements have already resulted in some successes in diverse fields, including human health, pharmacology, fisheries, environmental recovery or restoration, food and cosmetics industries, agriculture and chemistry. Examples of applications resulting from biotechnological developments include the use of (micro- and macro-) algae for the production of biofuels and the production of marine-derived polysaccharides, which are one of the most abundant renewable biomaterials found on land and in the oceans.
LPI (LP Information)' newest research report, the “Marine Biotechnology Industry Forecast” looks at past sales and reviews total world Marine Biotechnology sales in 2022, providing a comprehensive analysis by region and market sector of projected Marine Biotechnology sales for 2023 through 2029. With Marine Biotechnology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Marine Biotechnology industry.
This Insight Report provides a comprehensive analysis of the global Marine Biotechnology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Marine Biotechnology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Marine Biotechnology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Marine Biotechnology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Marine Biotechnology.
The global Marine Biotechnology market size is projected to grow from US$ 5084.9 million in 2022 to US$ 6806.3 million in 2029; it is expected to grow at a CAGR of 4.3% from 2023 to 2029.
The major players in global Marine Biotechnology market include Nofima, Sams, Aquapharm etc., and the market concentration rate is low. North America and Europe are main markets, they occupy over 60% of the global market. Marine Plant Technology is the main type, with a share about 60%. Pharmaceuticals and Nutritional Supplements are two key applications, they hold a share over 60%.
This report presents a comprehensive overview, market shares, and growth opportunities of Marine Biotechnology market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Marine Animal Technolog
Marine Plant Technology
Segmentation by application
Cosmetics
Pharmaceuticals
Fine Chemical
Nutritional Supplements
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Marinova
NEB
BiotechMarine
GlycoMar
Marine Biotech
Nofima
Sams
Aquapharm

Please note: The report will take approximately 2 business days to prepare and deliver.